RS51260B - Transdermalni sistem za dostavu gestodena - Google Patents
Transdermalni sistem za dostavu gestodenaInfo
- Publication number
- RS51260B RS51260B RSP-2010/0202A RSP20100202A RS51260B RS 51260 B RS51260 B RS 51260B RS P20100202 A RSP20100202 A RS P20100202A RS 51260 B RS51260 B RS 51260B
- Authority
- RS
- Serbia
- Prior art keywords
- gestodene
- drug
- containing layer
- transdermal delivery
- delivery system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Kompozicija za transdermalnu dostavu, naznačena time, da obuhvata sloj koji sadrži lek, a koji obuhvata Gestoden ili neki njegov ester i kerijer koji je izabran iz grupe koja se sastoji od poliizobutilena, polibutena, poliizoprena, polistirena, stiren izopren stiren blok polimera, stiren butadien stiren blok polimera i njihovih mešavina, a gde sloj koji sadrži lek poseduje rastvorivost za pomenuti Gestoden od ne više od 3% težine samoga sloja koji sadrži lek i gde Gestoden ili neki njegov ester je prisutan u količini koja se kreće u rasponu među 0.5 i 3% težine samoga sloja koji sadrži lek.Prijava sadrži još 21 patentni zahtev.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03078881 | 2003-12-12 | ||
| EP04078365A EP1541137B1 (en) | 2003-12-12 | 2004-12-10 | Transdermal delivery system of gestodene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51260B true RS51260B (sr) | 2010-12-31 |
Family
ID=34924031
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU20140050A RS53182B (sr) | 2003-12-12 | 2004-12-10 | Transdermalni sistem dostave hormona bez upotrebe pojačivača penetracije |
| RSP-2010/0202A RS51260B (sr) | 2003-12-12 | 2004-12-10 | Transdermalni sistem za dostavu gestodena |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU20140050A RS53182B (sr) | 2003-12-12 | 2004-12-10 | Transdermalni sistem dostave hormona bez upotrebe pojačivača penetracije |
Country Status (24)
| Country | Link |
|---|---|
| EP (2) | EP2138169B1 (sr) |
| CN (1) | CN101843603B (sr) |
| AR (1) | AR046762A1 (sr) |
| AT (1) | ATE457168T1 (sr) |
| CR (1) | CR8465A (sr) |
| CY (2) | CY1110637T1 (sr) |
| DE (1) | DE602004025444D1 (sr) |
| DK (2) | DK2138169T3 (sr) |
| ES (2) | ES2340925T3 (sr) |
| GT (1) | GT200400262A (sr) |
| HK (2) | HK1074801A1 (sr) |
| HN (1) | HN2004000526A (sr) |
| HR (2) | HRP20100254T1 (sr) |
| JO (1) | JO2606B1 (sr) |
| ME (1) | ME01069B (sr) |
| MY (2) | MY144053A (sr) |
| PE (1) | PE20051035A1 (sr) |
| PL (2) | PL2138169T3 (sr) |
| PT (2) | PT2138169E (sr) |
| RS (2) | RS53182B (sr) |
| SI (2) | SI1541137T1 (sr) |
| SV (1) | SV2006001970A (sr) |
| TW (1) | TWI257299B (sr) |
| UA (1) | UA89766C2 (sr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1594483E (pt) | 2003-02-21 | 2006-12-29 | Schering Ag | Penso transdérmico estável aos uv |
| US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| ES2795455T3 (es) | 2008-10-08 | 2020-11-23 | Agile Therapeutics Inc | Suministro transdérmico |
| WO2010042607A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc | Transdermal delivery |
| WO2010042610A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2410859A4 (en) | 2009-03-27 | 2013-03-13 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| AU2015203180B2 (en) * | 2010-09-06 | 2016-06-30 | Bayer Intellectual Property Gmbh | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
| HUE031326T2 (hu) | 2010-09-06 | 2017-07-28 | Bayer Ip Gmbh | Alacsony dózisú transzdermális tapaszok magas hatóanyagleadással |
| DE102010040299A1 (de) * | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
| MX2014008693A (es) * | 2012-01-27 | 2014-08-27 | Agile Therapeutics Inc | Administracion transdermica de hormonas. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4081537A (en) | 1975-10-10 | 1978-03-28 | Schering Aktiengesellschaft | Δ15 -Steroids and pharmaceutical compositions thereof |
| EP0394429B1 (de) * | 1988-10-27 | 1996-01-10 | Schering Aktiengesellschaft | Mittel zur transdermalen applikation enthaltend gestoden |
| US5512292A (en) * | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| MX9101787A (es) * | 1990-10-29 | 1992-06-05 | Alza Corp | Formulaciones,metodos y dispositivos anticonceptivos transdermicos |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4329242A1 (de) | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
| DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19906152B4 (de) * | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| ES2338860T3 (es) | 1999-11-24 | 2010-05-13 | Agile Therapeutics, Inc. | Sistema y procedimiento de administracion de anticonceptivos transdermica mejorado. |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| WO2002045701A2 (en) * | 2000-12-05 | 2002-06-13 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
-
2004
- 2004-10-12 UA UAA200607580A patent/UA89766C2/ru unknown
- 2004-11-18 JO JO2004159A patent/JO2606B1/en active
- 2004-12-10 DK DK09173898.9T patent/DK2138169T3/da active
- 2004-12-10 HN HN2004000526A patent/HN2004000526A/es unknown
- 2004-12-10 RS YU20140050A patent/RS53182B/sr unknown
- 2004-12-10 ES ES04078365T patent/ES2340925T3/es active Active
- 2004-12-10 PT PT91738989T patent/PT2138169E/pt unknown
- 2004-12-10 PL PL09173898T patent/PL2138169T3/pl unknown
- 2004-12-10 PL PL04078365T patent/PL1541137T3/pl unknown
- 2004-12-10 TW TW093138443A patent/TWI257299B/zh not_active IP Right Cessation
- 2004-12-10 CN CN2010101564978A patent/CN101843603B/zh active Active
- 2004-12-10 MY MYPI20045107A patent/MY144053A/en unknown
- 2004-12-10 PT PT04078365T patent/PT1541137E/pt unknown
- 2004-12-10 RS RSP-2010/0202A patent/RS51260B/sr unknown
- 2004-12-10 SI SI200431404T patent/SI1541137T1/sl unknown
- 2004-12-10 AT AT04078365T patent/ATE457168T1/de active
- 2004-12-10 DE DE602004025444T patent/DE602004025444D1/de active Active
- 2004-12-10 PE PE2004001230A patent/PE20051035A1/es active IP Right Grant
- 2004-12-10 SV SV2004001970A patent/SV2006001970A/es not_active Application Discontinuation
- 2004-12-10 SI SI200432127T patent/SI2138169T1/sl unknown
- 2004-12-10 EP EP09173898.9A patent/EP2138169B1/en active Active
- 2004-12-10 ME MEP-2010-79A patent/ME01069B/me unknown
- 2004-12-10 DK DK04078365.6T patent/DK1541137T3/da active
- 2004-12-10 GT GT200400262A patent/GT200400262A/es unknown
- 2004-12-10 EP EP04078365A patent/EP1541137B1/en active Active
- 2004-12-10 AR ARP040104605A patent/AR046762A1/es not_active Application Discontinuation
- 2004-12-10 ES ES09173898.9T patent/ES2445690T3/es active Active
-
2005
- 2005-10-07 HK HK05108895.4A patent/HK1074801A1/xx not_active IP Right Cessation
-
2006
- 2006-06-20 CR CR8465A patent/CR8465A/es unknown
-
2010
- 2010-01-12 HK HK10100292.3A patent/HK1132682A1/xx not_active IP Right Cessation
- 2010-03-31 MY MYPI2010001448 patent/MY152750A/en unknown
- 2010-05-04 HR HR20100254T patent/HRP20100254T1/hr unknown
- 2010-05-07 CY CY20101100401T patent/CY1110637T1/el unknown
-
2014
- 2014-01-24 HR HRP20140077TT patent/HRP20140077T1/hr unknown
- 2014-02-06 CY CY20141100099T patent/CY1115064T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS51260B (sr) | Transdermalni sistem za dostavu gestodena | |
| PT1061900E (pt) | Composicoes e metodos para libertacao de uma droga | |
| BR0109150A (pt) | Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente | |
| HRP20020158B1 (en) | Action of synergistic combination | |
| RS52057B (sr) | Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so | |
| RS51516B (sr) | Dodatna heterociklična jedinjenja i njihovo korišćenje kao antagonista metabotropnih receptora glutamata | |
| BRPI0507462A (pt) | compostos de quinolina substituìdos | |
| HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
| CY1108766T1 (el) | Συνθεσεις και μεθοδοι για την προληψη ή την μειωση της αντοχης των εντομων στα εντομοκτονα | |
| MXPA06000542A (es) | Sistema de administracion transdermica de hormonas: composiciones y metodos. | |
| DE602005003343D1 (de) | Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln | |
| RS50303B (sr) | Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem | |
| RS52671B (sr) | Poboljšani gel testosterona i postupak korišćenja | |
| ATE446744T1 (de) | Transdermale arzneimittelzubereitungen mit wirkstoffkombinationen zur behandlung der parkinson-krankheit | |
| HU193075B (en) | Method for producing plaster containing antiphlogistic agents | |
| RS51696B (sr) | Transdermalni granisetron | |
| NO162216B (no) | Fremgangsm te til fremstilling av antiflogistisk-mee plastere. | |
| TW200733980A (en) | Phase transitive breath care products | |
| HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
| JPH09208460A (ja) | 貼付剤 | |
| CN117224534A (zh) | 用于治疗皮肤损伤的内酰胺 | |
| BRPI0415725A (pt) | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa | |
| DK1300143T3 (da) | Plaster som indeholder 4-biphenyleddikesyre | |
| NO20073768L (no) | Transdermalt plaster med progesteron-A-spesifikke ligander (PRASL) som en aktiv ingrediens | |
| ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit |